HOME >> BIOLOGY >> NEWS
Cedars-Sinai Medical Center Physicians And Scientists Present Findings At Annual Meeting Of The Pediatric Academic Societies

LOS ANGELES (May 2, 1999) -- Researchers at Cedars-Sinai Medical Center are presenting three scientific lectures and several poster-session exhibits at the Pediatric Academic Societies' 1999 Annual Meeting May 1 through 4 in San Francisco.

The first lecture was presented at 9:45 a.m. Sunday, May 2, as part of a program on neuroprotective strategies for hypoxic-ischemic encephalopathy - the effort to reduce or prevent damage to brain cells when blood supply to the brain is reduced or blood to the brain contains insufficient oxygen.

For some time, researchers have thought that the administration of magnesium may have a "protective effect" on brain cells, although the exact mechanism has not been understood. Neonatologist Richard C. Krueger, Jr., M.D., Ph.D., discussed the results of a study that advances this theory, suggesting that the administration of magnesium "could have a dramatic impact on neural development." The study was conducted by researchers at Cedars-Sinai and Chicago Children's Hospital.

The researchers placed brain cells of embryonic chickens into a culture containing only a small amount of magnesium. After five days, they added another measured amount of magnesium, analyzing the cells 24 hours later for overall viability (the ability to live, grow and develop), apoptosis (disintegration), and proliferation (reproduction).

No change was seen in the level of disintegration but both cell viability and proliferation increased. A subsequent test indicated that the cells proliferating during the initial 24-hour period were precursors to glia cells - the supportive structures of the nervous system.

This rapid reproduction of glial precursors is believed to be at least partly due to activation of PI3 Kinase, an enzyme that interacts with other cell proteins and plays an instrumental role in cell growth and other activities. When wortmannin -- a substance that inhibits the activity of PI3 Kinase and is known to cause cell disintegr
'"/>

Contact: Sandra Van
Sandy@VanCommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
4-May-1999


Page: 1 2 3 4 5 6

Related biology news :

1. Heart transplant surgeon at Cedars-Sinai specializes in implanting mechanisms that allow a defective heart to rest while awaiting a transplant
2. Study at Cedars-Sinai Medical Center investigates possible protective effects of plant compounds on the uterus
3. Cedars-Sinai medical tip sheet (b)
4. Researchers at Cedars-Sinai Medical Center to present first documentation of man-made chemical contaminants in the amniotic fluid of unborn babies
5. Cedars-Sinai Medical Center study identifies for the first time a molecular mechanism behind hormonal response to stress
6. Cedars-Sinai Medical Tip Sheet For April 15 (A)
7. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
8. GenRISK Genetic Testing Program At Cedars-Sinai Medical Center Offers Patients New Hope In Confronting Disease
9. Cedars-Sinai Scientists Localize New Ataxia/Epilepsy Gene
10. Cedars-Sinai Tip Sheet For Dec. 21
11. Cedars-Sinai Scientist Finds Malignancy Gene In Tumor Cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received ... innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be assigned ... syringe. The company’s solutions are the first Wharton’s jelly allograft product to be recognized ...
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
(Date:7/22/2020)... ... July 21, 2020 , ... USDM Life ... and compliance, announces a new solution to manage regulated workloads on Microsoft Azure. ... their technology stack complies with FDA and global regulations. USDM's new managed service ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , the leading platform for ... Board (SAB) to research the medical potential of terpenes and the potential entourage ... terpenes. The board is focused on expanding the recently launched line of effects-based terpenes ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. ... a global leader in FDA compliance consulting has been named on its annual ... The list represents a unique look at the most successful companies within the ...
(Date:7/31/2020)... ... , ... R3 Stem Cell International is now offering patients the opportunity to ... total, patients may choose which extremities they would like treated. , Several studies have ... 2016). At R3 International, umbilical cord tissue is obtained from a lab with a ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. (Nasdaq: ... advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ... strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical ...
Breaking Biology Technology:
Cached News: